— Catalyst Pharmaceutical (NASDAQ: CPRX) reported third quarter 2019 earnings of $0.13 per share, vs. $0.11 per share expected.
— Net
product revenue came in at $30.9 million, vs. $33.2 million expected.
—
Expects full year 2019 revenues of approx. $100 million. Revenues in 2020
projected to be in the range of $135 million to $155 million.
— CPRX
shares fell 5.2% immediately following the announcement.